Advancing Cell Therapies with the Highest Quality Starting Material

The quality and consistency of the primary source material is directly related to the quality and efficacy of the final cell-based product. HemaCare is the global leader in providing human-derived biological products and apheresis collection services, directly enabling customers to advance autologous and allogeneic cell therapies. With 40 years of experience,

HemaCare has performed over 250,000 apheresis collections, developed the largest registry of healthy, repeat donors, and adopted the most stringent quality standards in the industry to provide customers with the highest quality primary cells available today. Cells are delivered with exceptional purity, viability, and cell quantity to ensure consistency and reproducibility. Additionally, our extensive custom services and product offering enable us to reliably meet customer specifications.

Learn More About HemaCare’s Role in Commercializing Patient Cell Therapies

Apheresis and Bone Marrow Collection

High-quality starting material has become an essential tool in the development of cell therapies. HemaCare’s collection services feature:

  • Recruitment from HemaCare’s robust pool of well-characterized, reliable and recallable donors
  • Pre-screening of donors to meet customized specifications and infectious diseases screenings after each collection
  • Forty years of apheresis collection expertise

HemaCare supplies customers with fresh and cryopreserved leukopaks and bone marrow aspirate.

Tissue Collection Services

Processing, Isolation, and Cryopreservation

Optimizing starting material prior to further manufacturing provides you with a head start in the development of patient cell therapies. HemaCare services include:

  • Cryopreservation of leukopaks, PBMCs, T cells, NK cells, and other cellular material
  • Isolated cell types purified by density gradient/immunomagnetic sorting procedures
  • Acceptance, processing, cryopreservation, and storage of healthy and patient collections

Cell isolation, processing, and cryopreservation services will be available in a GMP-compliant environment beginning in 2019.

Cell Isolation and Processing Services

Shipping and Logistics

HemaCare manages the transport of all samples globally, providing complete oversight from collection to final destination, ensuring your products are delivered on time meeting all regulatory specifications. HemaCare has partnered with best-in-class packaging manufacturers (NanoCool, Credo, Sherpa System, Evo, ThermoSafe, TruePak, among others) and commercial and specialty couriers (FedEx, UPS, CryoPort, QuikStat, Apollo, World Courier, among others). HemaCare’s cold chain logistics services include:

  • Batch release performed prior to shipment of cryopreserved products
  • Packaging and shipment customized to meet customer specifications
  • Superior cold chain logistics ensuring receipt of highest quality starting material

Cold Chain Logistics Services